scholarly article | Q13442814 |
P50 | author | Josef Penninger | Q1674391 |
Julia Charles | Q57966806 | ||
Jae Myun Lee | Q59681521 | ||
Kwang Hwan Park | Q60981157 | ||
Jin Woo Lee | Q64681744 | ||
P2093 | author name string | Anju Singh | |
Roland Baron | |||
Sutada Lotinun | |||
Jae-Hyuck Shim | |||
Sankar Ghosh | |||
Matthew B Greenblatt | |||
Changchun Xiao | |||
Jung-Min Kim | |||
Hwanhee Oh | |||
Dong Yeon Shin | |||
Dorothy Hu | |||
Ki-young Lee | |||
P2860 | cites work | Valosin-containing protein is a multi-ubiquitin chain-targeting factor required in ubiquitin-proteasome degradation | Q24291519 |
CSN controls NF-kappaB by deubiquitinylation of IkappaBalpha | Q24298155 | ||
Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast coupling | Q24319108 | ||
Involvement of valosin-containing protein, an ATPase Co-purified with IkappaBalpha and 26 S proteasome, in ubiquitin-proteasome-mediated degradation of IkappaBalpha | Q24329214 | ||
RANK is essential for osteoclast and lymph node development | Q24598872 | ||
Pathobiology of Paget's Disease of Bone | Q26824476 | ||
Mos10 (Vps60) is required for normal filament maturation in Saccharomyces cerevisiae | Q27930298 | ||
Mobilization of processed, membrane-tethered SPT23 transcription factor by CDC48(UFD1/NPL4), a ubiquitin-selective chaperone | Q27930650 | ||
A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly. | Q27935265 | ||
Escrt-III: an endosome-associated heterooligomeric protein complex required for mvb sorting | Q27939994 | ||
A systematic analysis of human CHMP protein interactions: additional MIT domain-containing proteins bind to multiple components of the human ESCRT III complex | Q28115418 | ||
CHMP5 is essential for late endosome function and down-regulation of receptor signaling during mouse embryogenesis | Q28508530 | ||
Syk, c-Src, the alphavbeta3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption | Q28592760 | ||
Genome-wide association identifies three new susceptibility loci for Paget's disease of bone. | Q29417073 | ||
Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice | Q29547898 | ||
The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins | Q29617399 | ||
Genetic regulation of osteoclast development and function | Q29617421 | ||
Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein | Q29619232 | ||
c-Src links a RANK/αvβ3 integrin complex to the osteoclast cytoskeleton | Q30010102 | ||
Juvenile paget's disease in an Iranian kindred with vitamin D deficiency and novel homozygous TNFRSF11B mutation | Q30437591 | ||
Juvenile Paget's disease with heterozygous duplication within TNFRSF11A encoding RANK | Q34307564 | ||
Contributions of the measles virus nucleocapsid gene and the SQSTM1/p62(P392L) mutation to Paget's disease. | Q34512953 | ||
Osteosarcoma in Paget's disease of bone | Q34574123 | ||
Abnormal osteoclasts and bone marrow fibrosis in Paget's disease of the bone | Q79366605 | ||
Recombinant osteoprotegerin for juvenile Paget's disease | Q81148009 | ||
Pathogenesis and management of Paget's disease of bone. | Q34795095 | ||
Role of NF-κB in the skeleton | Q35347883 | ||
Genome-wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget's disease of bone | Q35552797 | ||
Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone | Q35595884 | ||
Treatment of idiopathic hyperphosphatasia with intensive bisphosphonate therapy | Q35739746 | ||
Paget disease of bone | Q36029217 | ||
Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells | Q36223256 | ||
Mechanisms of disease: genetics of Paget's disease of bone and related disorders | Q36577488 | ||
Osteoclast-secreted CTHRC1 in the coupling of bone resorption to formation | Q37123948 | ||
TGF-β induces Wnt10b in osteoclasts from female mice to enhance coupling to osteoblasts | Q37181921 | ||
Bone remodeling: Multiple cellular interactions required for coupling of bone formation and resorption | Q37249047 | ||
TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation | Q37307155 | ||
Mechanisms of osteoclast-dependent bone formation | Q37414413 | ||
The p97-UFD1L-NPL4 protein complex mediates cytokine-induced IκBα proteolysis | Q37546931 | ||
Insights into the pathogenesis of Paget's disease | Q37730913 | ||
Recent advances in p97/VCP/Cdc48 cellular functions | Q37904023 | ||
The multiple faces of valosin-containing protein-associated diseases: inclusion body myopathy with Paget's disease of bone, frontotemporal dementia, and amyotrophic lateral sclerosis. | Q37926529 | ||
Shaping development with ESCRTs | Q37970884 | ||
Paget's disease of bone: clinical features and treatment. | Q39613756 | ||
Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation | Q40881030 | ||
Incidence and natural history of Paget's disease of bone in England and Wales. | Q45137415 | ||
Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo | Q47446256 | ||
Transgenic expression of CSF-1 in CSF-1 receptor-expressing cells leads to macrophage activation, osteoporosis, and early death. | Q48420792 | ||
Denosumab treatment for juvenile Paget's disease: results from two adult patients with osteoprotegerin deficiency ("Balkan" mutation in the TNFRSF11B gene). | Q50355957 | ||
IGFALS gene dosage effects on serum IGF-I and glucose metabolism, body composition, bone growth in length and width, and the pharmacokinetics of recombinant human IGF-I administration. | Q51328560 | ||
Osteoclast-derived complement component 3a stimulates osteoblast differentiation. | Q53069661 | ||
Some unusual features of Paget's disease of bone | Q55062854 | ||
Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis | Q57675131 | ||
Differential Gene Expression in Cultured Osteoblasts and Bone Marrow Stromal Cells From Patients With Paget's Disease of Bone | Q62129332 | ||
Transgenic mice that express Cre recombinase in osteoclasts | Q62829586 | ||
Interleukin-6, IL-6 receptor, and IL-6 nuclear factor gene expression in paget's disease | Q63407797 | ||
Ultrastructural characteristics of osteoclasts in Paget's disease | Q68709329 | ||
Leukemia inhibitory factor is mitogenic to osteoblasts | Q73640200 | ||
Fragile bones and macrocranium | Q74258271 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | NF-κB | Q411114 |
P304 | page(s) | 1283-1301 | |
P577 | publication date | 2015-07-20 | |
P1433 | published in | Journal of Experimental Medicine | Q3186912 |
P1476 | title | CHMP5 controls bone turnover rates by dampening NF-κB activity in osteoclasts | |
P478 | volume | 212 |
Q43850672 | A rheostat tuning thymic selection |
Q97423430 | Activating PIK3CA mutation promotes osteogenesis of bone marrow mesenchymal stem cells in macrodactyly |
Q34544054 | Characterization and Genetic Analyses of New Genes Coding for NOD2 Interacting Proteins |
Q64925962 | Deubiquitinating Enzymes and Bone Remodeling. |
Q92383538 | Development and Genome Sequencing of a Laboratory-Inbred Miniature Pig Facilitates Study of Human Diabetic Disease |
Q59066621 | Discovery of a periosteal stem cell mediating intramembranous bone formation |
Q57265483 | EphrinB2 Signalling in Osteoblast Differentiation, Bone Formation and Endochondral Ossification |
Q47825435 | Fine-tuning of thymocyte development by ubiquitination-mediated stability control of the ESCRT protein CHMP5. |
Q64068457 | Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer |
Q52587851 | Human Genetics of Sclerosing Bone Disorders. |
Q51308225 | Inactivation of Regulatory-associated Protein of mTOR (Raptor)/Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling in Osteoclasts Increases Bone Mass by Inhibiting Osteoclast Differentiation in Mice. |
Q27312272 | Involvement of Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-induced Incomplete Cytokinesis in the Polyploidization of Osteoclasts |
Q89814227 | Ophiopogonin D promotes bone regeneration by stimulating CD31hi EMCNhi vessel formation |
Q90056276 | Osteoclasts are not a source of SLIT3 |
Q47944184 | Osteoimmunology: The Conceptual Framework Unifying the Immune and Skeletal Systems. |
Q40182044 | Post-translational control of T cell development by the ESCRT protein CHMP5. |
Q47678861 | The ESCRT protein CHMP5 escorts αβ T cells through positive selection. |
Q91650493 | The Role of Bone-Derived Exosomes in Regulating Skeletal Metabolism and Extraosseous Diseases |
Q92622339 | The auxiliary ESCRT complexes provide robustness to cold in poikilothermic organisms |
Q57818480 | USP20 (Ubiquitin-Specific Protease 20) Inhibits TNF (Tumor Necrosis Factor)-Triggered Smooth Muscle Cell Inflammation and Attenuates Atherosclerosis |
Q38754621 | c-Jun N-Terminal Kinases (JNKs) Are Critical Mediators of Osteoblast Activity In Vivo |
Search more.